These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34460968)

  • 21. Impella support compared to medical treatment for post-cardiac arrest shock after out of hospital cardiac arrest.
    Karatolios K; Chatzis G; Markus B; Luesebrink U; Ahrens H; Dersch W; Betz S; Ploeger B; Boesl E; O'Neill W; Kill C; Schieffer B
    Resuscitation; 2018 May; 126():104-110. PubMed ID: 29522829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of Impella CP insertion during cardiac arrest: A single center experience.
    Kamran H; Batra S; Venesy DM; Patten RD; Waxman S; Pyne C; Shah SP
    Resuscitation; 2020 Feb; 147():53-56. PubMed ID: 31891791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous left ventricular assist support is associated with less pulmonary congestion and lower rate of pneumonia in patients with cardiogenic shock.
    Haberkorn S; Uwarow A; Haurand J; Jung C; Kelm M; Westenfeld R; Horn P
    Open Heart; 2020 Nov; 7(2):. PubMed ID: 33132209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short term outcomes of Impella in cardiogenic shock: A review and meta-analysis of observational studies.
    Iannaccone M; Albani S; Giannini F; Colangelo S; Boccuzzi GG; Garbo R; Brilakis ES; D'ascenzo F; de Ferrari GM; Colombo A
    Int J Cardiol; 2021 Feb; 324():44-51. PubMed ID: 32971148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal membrane oxygenation and microaxial left ventricular assist device in cardiogenic shock: Choosing the right mechanical circulatory support to improve outcomes.
    Dagher O; Noly PE; Ben Ali W; Bouabdallaoui N; Geicu L; Lamanna R; Malhi P; Romero E; Ducharme A; Demers P; Lamarche Y
    JTCVS Open; 2023 Mar; 13():200-213. PubMed ID: 37063130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock.
    Pieri M; Sorrentino T; Oppizzi M; Melisurgo G; Lembo R; Colombo A; Zangrillo A; Pappalardo F
    J Interv Cardiol; 2018 Dec; 31(6):717-724. PubMed ID: 30460719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac power output index to define hemodynamic response to Impella support in cardiogenic shock.
    Sern Lim H
    Int J Artif Organs; 2022 Jul; 45(7):598-603. PubMed ID: 35578554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Impella 5.0 and extracorporeal left ventricular assist device in patients with cardiogenic shock.
    Kondo T; Morimoto R; Mutsuga M; Fujimoto K; Okumura T; Shibata N; Kazama S; Kimira Y; Oishi H; Kuwayama T; Hiraiwa H; Usui A; Murohara T
    Int J Artif Organs; 2021 Nov; 44(11):846-853. PubMed ID: 34488481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients.
    Schäfer A; Werner N; Burkhoff D; Sieweke JT; Zietzer A; Masyuk M; Junker Udesen NL; Westenfeld R; Møller JE
    Front Cardiovasc Med; 2020; 7():74. PubMed ID: 32478095
    [No Abstract]   [Full Text] [Related]  

  • 32. Preliminary experience with Impella Recover(®) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit.
    Bresson D; Sibellas F; Farhat F; Jegaden O; Kirkorian G; Bonnefoy E
    Arch Cardiovasc Dis; 2011 Aug; 104(8-9):458-64. PubMed ID: 21944148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the Impella Device for Acute Coronary Syndrome Complicated by Cardiogenic Shock - Experience From a Single Heart Center With Analysis of Long-term Mortality.
    Schroeter MR; Köhler H; Wachter A; Bleckmann A; Hasenfuß G; Schillinger W
    J Invasive Cardiol; 2016 Dec; 28(12):467-472. PubMed ID: 27529657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock-a critical appraisal of current data.
    Wernly B; Seelmaier C; Leistner D; Stähli BE; Pretsch I; Lichtenauer M; Jung C; Hoppe UC; Landmesser U; Thiele H; Lauten A
    Clin Res Cardiol; 2019 Nov; 108(11):1249-1257. PubMed ID: 30900010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
    Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
    J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of Mortality and Outcomes of Acute Severe Cardiogenic Shock Treated with the Impella Device.
    Rohm CL; Gadidov B; Leitson M; Ray HE; Prasad R
    Am J Cardiol; 2019 Aug; 124(4):499-504. PubMed ID: 31262498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz AP; Masoudi FA; Messenger JC; Parzynski CS; Ngufor CG; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA Netw Open; 2021 Feb; 4(2):e2037748. PubMed ID: 33616664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bridging INTERMACS 1 patients from VA-ECMO to LVAD via Impella 5.0: De-escalate and ambulate.
    Bertoldi LF; Pappalardo F; Lubos E; Grahn H; Rybczinski M; Barten MJ; Legros T; Bertoglio L; Schrage B; Westermann D; Lapenna E; Reichenspurner H; Bernhardt AM
    J Crit Care; 2020 Jun; 57():259-263. PubMed ID: 32061461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features and outcomes in patients with cardiogenic shock complicating acute myocardial infarction: early vs recent experience with impella.
    Singh H; Mehta RH; O'Neill W; Kapur NK; Lalonde T; Ohman M; Ghiu I; Chen-Hsing Y; Dutcheshen K; Schreiber T; Rosman H; Kaki A
    Am Heart J; 2021 Aug; 238():66-74. PubMed ID: 33848505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications related to the access site after transaxillary implantation of a microaxial left ventricular assist device.
    Lewin D; Nersesian G; Lanmüller P; Schoenrath F; Falk V; Potapov EV; Ott S
    J Heart Lung Transplant; 2023 May; 42(5):679-687. PubMed ID: 36653272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.